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OBJECTIVE: To understand potential barriers to phy-
sician-initiated discussions about Implantable Cardio-
verter Defibrillator (ICD) deactivation in patients with
advanced illness.
DESIGN: Qualitative one-on-one interviews.
PARTICIPANTS: Four electrophysiologists, 4 cardiolo-
gists, and 4 generalists (internists and geriatricians)
from 3 states.
APPROACH: Clinicians were interviewed using open-
ended questions to elicit their past experiences with
discussing deactivating ICDs and to determine what
barriers might impede these discussions. Transcripts of
these interviews were analyzed using the qualitative
method of constant comparison.
RESULTS: Although many physicians believed that
conversations about deactivating ICDs should be in-
cluded in advance care planning discussions, they
acknowledged that they rarely did this. Physicians
indicated that there was something intrinsic to the
nature of these devices that makes it inherently difficult
to think of them in the same context as other manage-
ment decisions at the end of a patient’s life. Other
explanations physicians gave as to why they did not
engage in conversations included: the small internal
nature of these devices and hence absence of a physical
reminder to discuss the ICD, the absence of an
established relationship with the patient, and their
own general concerns relating to withdrawing care.
CONCLUSION: Whereas some of the barriers to dis-
cussing ICD deactivation are common to all forms of
advance care planning, ICDs have unique characteris-
tics that make these conversations more difficult.
Future educational interventions will need to be
designed to teach physicians how to improve commu-
nication with patients about the management of ICDs
at the end of life.
KEY WORDS: palliative care; advanced technology; communication;
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INTRODUCTION
There is a large body of evidence demonstrating that Implant-
able Cardioverter Defibrillators (ICDs) decrease the incidence
of sudden cardiac death,
1–4 but little is known about the end-
of-life care for these patients, most of whom die from either
worsening of their underlying heart disease or other chronic
illnesses. As a patient’s condition deteriorates, physiologic
changes (intrinsic and extrinsic to the heart) may affect the
cardiac conduction system, leading to more arrhythmias and
increasing the frequency of shocks. One study showed that up
to 20% of family members of deceased patients reported that
their loved one received a shock from their ICD in the last days
to minutes of life.
5 Because ICD shocks can cause pain and
anxiety and may not prolong a life of acceptable quality,
6–8 it is
appropriate to consider ICD deactivation as a patient’s clinical
status worsens and death is near. Previous work has shown
that clinicians and patients rarely engage in discussions about
deactivating ICDs and most remain active until death.
5
Given the expanding indications for ICD implantation,
1–4,9,10
the issue of device deactivation will become more relevant as
the population ages. Under current Medicare criteria, approxi-
mately 3–4 million patients are currently eligible to receive
these devices, with 400,000 new patients eligible each
year.
3,11–13 Prior research has suggested that patients prefer
physicians to initiate discussions about treatment options at
the end of life. As most patients with an ICD will face a decision
about deactivating the device near the end of their lives, we
conducted this study to better understand barriers to clinician-
initiated discussions about ICD deactivation. Because these
conversations are infrequent and complex, it would be difficult
to begin exploring the barriers impeding deactivation discus-
sions using a traditional, closed-ended survey instrument.
Instead, the qualitative method of using open-ended questions
to conduct initial explorations
14–16 is more suited for under-
standing how physicians conceptualize the role of the device
Data from this study were presented at the 2006 national meeting of
the American Association of Hospice and Palliative Medicine (AAHPM).
JGIM
2and determining barriers that impede engaging in conversa-
tions with patients about deactivating ICDs.
METHODS
Study Design and Data Collection
We conducted a qualitative study using in-depth interviews
17,18
of physicians by means of open-ended questions from a pre-
determined discussion guide (Table 1). The questions for the
guide were determined by consensus among several of the
investigators (NG, EB, RSM) using both their clinical experiences
with this issue and their expertise in qualitative methods. The
guide begins with having physicians describe how they view their
individual role in the overall care of patients with ICDs and how
they explain to patients that they need an ICD. (These data are
not reported in this manuscript.) Next, physicians are asked to
describe a particularly memorable experience(s) relating to ICD
deactivation discussions.(Ofnote,many ICDs are multifunction-
al devices that may also perform a pacing or resynchronization
function. For purposes of this discussion, the term deactivation
only refers to turning off the shocking function of a defibrillator).
During the course of describing this conversation, physicians
were probed to determine what difficulties they encountered
during these conversations. Finally, the interviewer described to
the participants the medical literature revealing the low preva-
lence of these discussion in routine care
5 and asked clinicians
why they thought these discussions happen so rarely.
Although many clinicians may care for patients near the end
of life with ICDs, the investigators chose to focus on primary
care physicians and those specialists who would be most
involved with a patient’s ICD. Therefore, we enrolled 4 groups
of clinicians: general internists, geriatricians, cardiologists,
and electrophysiologists. We believed that the most efficient
way to determine barriers to these conversations was to
interview clinicians who have had these discussions, so we
only enrolled physicians who previously had a conversation
about deactivation. In addition, physicians had to be in
practice at least 1 year. To identify eligible physicians, the
investigators sent out “broadcast” emails to the divisions of
each of these 4 specialties at major academic medical centers
throughout the greater New York City area (including New
Jersey and Connecticut); personally contacted individual
physicians whom they thought might have had such discus-
sions (e.g., physicians specializing in palliative care, cardiolo-
gists with a primarily geriatric population); and asked
physicians participating in the study to identify other potential
clinicians whom they thought might have had these conversa-
tions. We were not able to identify family physicians who had
these discussions, and this may be because of the limited role
these clinicians play in the New York City metro area.
The investigators used purposeful sampling to balance the
number of physicians of each type that were enrolled in the
study. The research protocol was approved by the institutional
review board of the principal investigator’s medical school, and
all physicians signed informed consent. All physicians were
interviewed by the primary investigator (NG) either in person in
their office or via telephone. All interviews were audio-taped
and subsequently transcribed.
Data Analysis
Weusedtheconstantcomparativemethod
18,19ofqualitativedata
analysis to develop and implement consistent and comprehen-
sive coding of the open-ended data. First, the data were reviewed
line-by-lineuntilaconceptbecameapparentatwhichtimeacode
was assigned. As more data were reviewed, the code was further
refined. Subsequent transcripts were then analyzed and com-
pared to the list of codes to ascertain whether they reflected the
same concepts.
20 New codes were added as needed until no new
concepts emerged with successive interviews (i.e., thematic
saturation). All transcripts were independently reviewed and
coded by 3 of the reviewers (NG, ET, RSM) who met to discuss
the interviews and the coding structure on a regular basis.
Discrepancies occurred rarely (<5 times), and related more to
refining themes than to determining to which category a par-
ticular passageshould be assigned. Incases ofdisagreement, the
3 investigators came to a negotiated consensus through further
review and discussion of the context and content, as recom-
mended by experts in qualitative analysis.
21 The group deter-
minedbyconsensus at whichpointnonewthemesemergedfrom
thedata.Atthistime,itwasdecidedthatthematicsaturationhad
been reached and thus the data collection period was closed.
RESULTS
Thematic saturation was achieved after 12 participant inter-
views, and their characteristics are shown in Table 2.
When asked, almost every physician agreed that conversa-
tions about ICD deactivation should occur, but they all
acknowledged that they rarely did this. Clinicians understood
the importance of discussing ICD deactivation, but had dif-
ficulty translating the theoretical importance of these conversa-
tions to real-life scenarios. As described by a female Internist:
It hadn’to c c u r r e dt om et ot u r ni to f fu n t i l[ t h ec a r d i o l o g y
fellow said] you could turn these things off and I’ml i k e ,‘oh,
okay.’ Im e a ni tw a s n ’t something that I had ever encoun-
tered, and it crossed my mind on a technical level, but not
really, ‘oh, I should have this conversation.
Table 1. Question Guide For In-Depth, Open-ended Interviews With
Clinicians
Questions
1. Explain to me how you see your role as a clinician in terms of the
overall health of the patient.
–Probe to determine how they see their role in terms of guiding medical
care/patient decision making.
–Probe to see if doctors see themselves as primary care provider for
patients especially for those with ICDs.
2. Tell me how you explain to patients that they need an ICD.
–Probe to see if information about prognosis, life-expectancy, and
deactivation is given at time of implantation.
3. We are trying to understand more about situations in which doctors
might consider deactivating ICDs. Have you ever been involved in
the care of a patient who needed a device deactivated? Tell me
about your experience.
–Probe both for experience discussing deactivating and experience
with actually turning devices off.
4. Previous research in this issue by our team has found that
conversations about deactivating ICDs in patients with advanced
illness rarely happens. Why do you think this might be?
–Probe to ask if these conversations are different than others at the
end of life.
5. Is there anything else I should ask so I can better understand how
you deal with terminally ill/dying patients and their ICDs?
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conversations, participants postulated that there was some-
thing intrinsic to the nature and function of these devices that
made it inherently difficult to think of them in the same
context as other management decisions at the end of a
patient’s life. One physician described this as follows:
People go on and off medications all the time; I put
someone on Lasix, I increase their Lasix, I stop their Lasix,
no big deal. You can change it again and again, but
turning off a [defibrillator] is; it’s like crossing a bridge to a
certain extent. It’ss a y i n g ,‘you know, we have gone as far
as we can go and you’re not going to need this down the
road you’re traveling and we’re going to shut it off.’ There’s
a finality to turning it off that is not the same as just
saying, well we’ll stop this medication [and then later] we
can restart it, because if you’ve made the decision to
stop…the surveillance of a defibrillator, if you’ve made it
for the right reasons, you’re not going to be turning it back
on.”—male cardiologist
Another cardiologist suggested that these conversations are
difficult to include in the context of other conversations because
of the primary life-saving role of these devices. As she described:
When you start talking about ... turning it off, then you
are sort of shutting off the hope.
In addition to its overall role, the small, unseen nature of the
device makes it difficult for physicians to remember to include
them as part of larger discussions about advance care planning,
as characterized by a female cardiologist who stated:
I think that one thing is that people don’t think about
[turning it off] because it’si n t e r n a l i z e d .
Whereas some clinicians thought that the differences between
ICDs and other technologies (e.g., ventilators, dialysis) used at
the end of life make conversations about deactivation more
difficult,otherclinicians alsobelievedthatcertain characteristics
unique to the ICD make deactivation conversations easier.
Well, I think it’s different than a respirator, for example,
because it’s, you know, it’s not like you turn [the ICD] off
and the person dies.”—female electrophysiologist
Another female electrophysiologist described this phenom-
enon similarly when she said,
Well, I don’t know, I think it makes it easier because it’s
sort of a random event in a sense. That, you know, by
turning off the switch you’re not killing the person.
Difficulties in including ICD deactivation discussions into
other forms of care planning are not limited to the nature of the
device itself. Another consistent theme was that physicians
(both generalists and specialists) lacked the sense of rapport
with patients to be able to discuss ICD deactivation. As a
female electrophysiologist stated:
I think you have to develop some sort of rapport with the
patient before you can start to discuss [ICD deactiva-
tion]. For one thing, you don’t want to scare the patient
the first time you see them into thinking that they’re
dying.
Another clinician also described the importance of an
established relationship by stating:
I think most doctors don’t do [ICD deactivation discussions]
well. I think it is because they don’th a v et h et i m e… they
don’t know the patients well enough because of the way you
practice now with insurance, you know, you don’t develop
t h eb o n dw i t hp a t i e n t sn o wt h ew a yy o uu s e dt o . ”—female
cardiologist
A final barrier to communicating about ICD deactivation
was a feeling that deactivation was withdrawing life-sustaining
care. As a clinician stated:
I think that people just don’t think of turning off things
that were already started, even though it’s like all
technology, even though we say ethically and legally that
there’s no difference between withholding and withdraw-
ing, I think for a lot of life-sustaining therapies, in
practice it seems like it’s different.”—female internist
DISCUSSION
Results from these qualitative interviews with clinicians from a
variety of specialties in both academic and private practice
settings demonstrate that although these physicians believe
conversations about deactivating ICDs should happen as part
of the other advance care planning discussions for patients
with serious illness, this rarely occurs. Some of the reasons
why these conversations do not occur seem to be similar to the
Table 2. Demographics of Physician Participants
Characteristics
Age
Range 33–61
Median (SD) 36.5 (9.2)
Years since completing training
Range 1–29
Median (SD) 3.5 (9.2)
Gender
Female 7
Specialty
Cardiology 4
Electrophysiology 4
Generalist(generalists evenly
split between Internists and
geriatricians)
4
Ethnicity
White 8
Asian 4
Practice Setting
Hospital-Associated 9
Private 3
Location
New York 10
New Jersey 1
Connecticut 1
4 Goldstein et al.: Physician Barriers to ICD Deactivation Discussions JGIMlarger literature on advance care planning (i.e., those discus-
sions where patients’ and their families’ goals of care are
elicited and treatment plans adjusted to be in line with those
goals
22), whereas others are unique to the ICD.
Many physicians in this study felt that because of a lack of
time, they did not have a relationship with patients that would
facilitate discussions about ICD deactivation—a finding other
investigators have noted when examining barriers to advance
care planning for patients with a variety of illnesses.
23,24
Clinicians also noted that they did not “do discussions well”
and were concerned that they would either take away patients’
hope or raise concerns about death; these are all concepts that
have been found in other studies exploring barriers to advance
care planning.
23–26 Physicians also discussed general con-
cerns with withdrawing therapies. Whereas discussion about
the withholding or withdrawing treatments are considered the
same by ethicists,
27 it is known that physicians draw a
distinction between these 2 treatments.
28–30
There were issues relating to ICD deactivation, however,
that were unique to the nature of the device itself. The majority
of patients who have hemodialysis or ventilators withdrawn
(the two most frequently studied technologies that are com-
monly withdrawn,
31–37) will often die within hours to weeks.
The interval between ICD deactivation and patient death may
be much longer given the unpredictable nature of malignant
arrhythmias. Because of this distinction between ICDs and
other advanced technologies, clinicians who engage in con-
versations about deactivation are somehow insulated from
feeling that they are “killing the person.” Both hemodialysis
and ventilator support also require large machinery, which
creates a physical reminder that advanced technologies are
being used to sustain life. In addition, these interventions have
a large impact on the patient’s overall quality of life. Because
the ICD is so small and innocuous, its size does not create a
daily interference with a patient’s quality of life; therefore,
discussions about their management at the end of life may not
seem so pressing to clinicians. It would seem as though the
nature of the device makes it less noticeable, but its small
physical size seems to be not correlated to the large ethical
dilemma it creates for physicians.
It is noteworthy that despite the difficulties added by the
unique nature of the ICD, every clinician who participated in this
study (whether in the role of primary care provider or specialist)
felt they had a role in these conversations. Traditionally, one
might assume that the job of having “difficult conversations” is
that of the primary care provider, but there were no participants
who expressed that they should be excluded from these con-
versations based on their medical subspecialty.
These data make it clear that clinicians believe they should
engageinconversationsaboutICDdeactivation,butthedifficulty
lies in creating effective future interventions to make these
conversations easier. These conversations are made even more
complex by the fact that in qualitative studies with patients
(reported separately in this issue of the Journal) we found that
relatively healthy community-dwelling outpatients with ICDs
may not wish to engage in conversations regarding ICD deacti-
vation. Although educational interventions have shown signifi-
cant improvements in facilitating communication between
clinicians and patients with advanced illness,
38–40 the data
reported here demonstrate that there are unique barriers to
communication about ICD deactivation, which might benefit
from future interventions specifically designed for conversations
about the management of these devices. These tools will need to
take into account patients’ reluctance to engage in these
conversations, as well as the unique nature of the ICD and how
this might hinder conversation.
As the number of implanted devices continues to expand in
the future because of expanding eligibility and reimbursement,
these conversations will be encountered with more frequency.
Only by assuring that conversations about ICD deactivation
routinely occur for all patients with advanced illness can we
assure that patients and their families have the highest quality
of care near the end of life.
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